U.S. Tech Hardware Stock News

Why CareDx stock is getting attention now CareDx (CDNA) has caught investor interest after recent share price moves, with the stock showing a mix of shorter term pressure and stronger longer term returns that raise fresh questions about valuation and risk. See our latest analysis for CareDx. The recent pullback, including a 1-day share price return of -1.24% and 7-day share price return of -5.52%, comes after a stronger 1-year total shareholder return of 45.98%. This suggests momentum has...

Why Cognex’s latest AI vision launch matters for the stock Cognex (CGNX) is back in focus after quarterly results beat expectations and the company rolled out its modular In-Sight 6900 Vision Controller, a new AI-powered system aimed at complex industrial inspection workloads. See our latest analysis for Cognex. The recent In-Sight 6900 launch and stronger quarterly results have arrived alongside powerful share price momentum, with a 90-day share price return of 44.44% and a 1-year total...

Ball (BALL) has just reported Q1 2026 results with investors looking back at recent momentum, including Q4 2025 revenue of US$3.3b, basic EPS of US$0.74 and trailing twelve month EPS of US$3.33 and net income of US$912m, set against a share price of US$57.11. Over the last few quarters revenue has moved from US$2.9b in Q4 2024 to around US$3.3b in Q4 2025, while quarterly EPS has ranged from a small loss in Q4 2024 to US$1.19 in Q3 2025 and US$0.74 in Q4 2025, giving investors a clearer view...

If you are wondering whether Biogen's current share price lines up with its underlying value, the recent performance gives you plenty to think about. The stock closed at US$189.13 recently, with returns of 3.1% over 7 days, 6.6% over 30 days, 6.4% year to date and 61.9% over the past year. The 3 year and 5 year returns sit at 39.8% and 32.1% declines respectively. These moves come as Biogen stays in focus in the large cap biotech space, with ongoing attention on its pipeline and portfolio...

Event context and recent stock performance Apellis Pharmaceuticals (APLS) has drawn fresh attention after recent trading data showed the stock flat over the past day, slightly higher over the past month, and sharply positive over the past 3 months and year. See our latest analysis for Apellis Pharmaceuticals. The latest share price of $40.97 sits alongside a 90 day share price return of 76.98% and a 1 year total shareholder return of 114.28%. The 3 and 5 year total shareholder returns remain...

Wondering if HCI Group at around US$154 per share still offers value, or if most of the opportunity is already priced in. The stock has been choppy recently, with a 2.1% decline over the last 7 days, a 1.1% gain over the last month, and returns of 6.2% over 1 year and very large gains over 3 and 5 years. Recent coverage around the stock has focused on its long run-up over the past few years and how sentiment has shifted as the year to date return stands at a 15.8% decline. Together, these...

TG Therapeutics, Inc. has reported its first-quarter 2026 results, with revenue rising to US$204,920,000 from US$120,860,000 a year earlier and net income increasing to US$19,780,000 from US$5,060,000, lifting basic earnings per share from continuing operations to US$0.14 and diluted earnings per share to US$0.12. The strong quarterly performance underscores ongoing traction for Briumvi in multiple sclerosis and sets the backdrop for the company’s planned subcutaneous formulation launch,...

Q1 2026 results: earnings reset after a strong year CNA Financial (CNA) opened 2026 with Q1 revenue of US$3.7b and basic EPS of US$0.78 on net income of US$211m, setting a different tone from the higher quarterly earnings seen through 2025. Over the past year, revenue has ranged from US$3.6b to US$3.8b per quarter while basic EPS moved between US$0.08 and US$1.49, feeding into trailing 12 month EPS of US$4.48 and net income of US$1.2b as margins have shifted quarter to quarter. For investors,...

Q1 2026 results reset the earnings baseline Loews (L) opened 2026 with Q1 revenue of US$4.6b and basic EPS of US$1.63, alongside net income of US$337m and a reported combined ratio of 102.2%. Over the past year, the company has seen revenue move from US$4.5b in Q1 2025 to US$4.6b in Q1 2026, while trailing twelve month EPS sits at US$7.88 on net income of US$1.63b. With trailing net profit margin at 8.8% and the latest quarter showing a combined ratio above 100%, the update gives investors a...

Donaldson Company (NYSE:DCI) has completed its acquisition of Facet Filtration. The deal expands Donaldson's reach into aerospace, defense, and power generation end markets. The acquisition broadens the Industrial Solutions segment and diversifies the company's revenue base. Donaldson Company, trading at $86.28, has seen its stock return 32.7% over the past year and 41.9% over three years, with a 47.3% return over five years. The completion of the Facet Filtration acquisition adds new...

Kadant Inc. has already reported first-quarter 2026 results, posting sales of US$281.51 million and net income of US$25.51 million, both higher than a year earlier, with basic and diluted EPS from continuing operations rising to US$2.16. This combination of revenue and earnings growth, following earlier expectations for a rebound from last year’s decline, highlights improving operating momentum and confidence in Kadant’s underlying demand drivers. We’ll now examine how Kadant’s higher...

Investors may be asking whether MongoDB stock is still priced attractively after its performance in recent years, or if much of the easier upside has already been realized. The share price last closed at US$266.68, with returns of 3.3% over 7 days, 5.4% over 30 days, a year-to-date decline of 33.3%, and 54.8% over 1 year. Recent market attention on MongoDB has focused on its role in database and developer tooling, with investors reacting to product updates and partnerships that keep it in...

In late April 2026, Starbucks reported second‑quarter results showing year‑over‑year growth in revenue and net income, raised its full‑year earnings outlook, and then in early May launched cash tender offers of up to US$1.10 billion to repurchase portions of eight senior note issues. Together, the stronger earnings, improved guidance, and planned debt repurchases highlight how the “Back to Starbucks” turnaround and balance sheet management are reshaping the company’s financial profile. Next,...

Polestar Automotive Holding UK: What Recent Returns Signal for Investors Polestar Automotive Holding UK (PSNY) has attracted attention after a sharp move in its share price over the past 3 months, in contrast with weaker returns over the past year and since listing. Over the past day and week, the stock has posted mixed short term returns, with a slight 1 day decline and a positive move of about 6% over the past week. Over the month, the stock shows a 4% decline, while the past 3 months...

Investors watching Diversified Healthcare Trust (DHC) got fresh numbers for Q1 2026, with funds from operations (FFO) of US$22.8 million and FFO per share of US$0.09 setting the tone for the latest update. Over recent quarters the company has seen quarterly FFO move from US$11.8 million in Q4 2024 to US$13.6 million in Q2 2025, then to US$4.9 million in Q4 2025 before reaching US$22.8 million in Q1 2026. Trailing twelve month FFO per share sits at US$0.15 against a backdrop of continuing net...

Why Versigent (VGNT) Is On Investors’ Radar Today Versigent (VGNT) has drawn fresh attention after recent trading, with the stock last closing at $37.50 and showing double digit returns over the past week and month. See our latest analysis for Versigent. The recent 1-day share price return of 3.7% and 30-day share price return of 33.5%, on top of a 24.2% year to date share price return, point to momentum building rather than fading for Versigent. If you are looking for other ideas while...

If you are wondering whether Old Republic International at around US$39.25 still offers value after a strong multi year run, it helps to break the story into recent returns, news flow, and what different valuation tools are actually saying. The stock is currently down 2.3% over the last week and 2.8% over the last month, with a 9.3% decline year to date, yet it still shows a 12.3% return over 1 year and triple digit returns over 3 and 5 years. Recent news coverage around Old Republic...

Navigator Holdings Ltd. has released its first-quarter 2026 results, reporting revenue of US$140.62 million versus US$151.41 million a year earlier, while net income rose to US$35.46 million from US$27.04 million, lifting diluted EPS from continuing operations to US$0.54 from US$0.39. The combination of lower revenue but higher earnings and EPS points to improved profitability and cost discipline, which could influence how investors assess the company’s efficiency and earnings...

Recently, Goldman Sachs added Futu Holdings to its APAC Conviction List, maintaining a positive rating and highlighting its exposure to Hong Kong’s capital markets. This endorsement places fresh emphasis on Futu’s role as a digital brokerage platform positioned to benefit from shifts in regional IPO activity and trading sentiment. Next, we’ll explore how Goldman Sachs’ Conviction List inclusion interacts with Futu’s earnings-focused growth narrative and evolving capital-markets...

Fitch upgraded Vistra's (NYSE:VST) long-term issuer rating to investment grade (BBB-), reflecting changes in the company’s business profile and credit metrics. The rating action is supported by long-term power agreements Vistra has secured with Amazon and Meta for data center demand. Vistra also completed the acquisition of Cogentrix Energy, adding gas-fired generation assets to its portfolio. Vistra operates as a power producer and retail electricity supplier, and these developments tie...

Why Visteon Stock Is Back in Focus After Fresh Guidance Visteon (VC) is back on watch after reporting first quarter 2026 results, with sales of US$954 million and net income of US$31 million, while also reaffirming full year 2026 earnings guidance. See our latest analysis for Visteon. After the guidance update and first quarter numbers, attention has shifted back to how the stock has been trading. A 20.6% 1 month share price return has helped lift year to date gains to 13.8%, while the 1 year...

Linde (NasdaqGS:LIN) is back in focus after reporting better than expected first quarter 2026 earnings, supported by 8% sales growth, firm margins, strong cash generation, and another dividend increase, alongside reiterated full year guidance. See our latest analysis for Linde. The recent earnings beat, dividend increase and recognition in sustainability indices have kept interest in Linde high, with the stock posting a 16.6% year to date share price return and an 82.2% five year total...

International General Insurance Holdings Ltd. reported past first-quarter 2026 results showing revenue of US$125.7 million and net income of US$21.7 million, both lower than a year earlier, with diluted EPS from continuing operations of US$0.49. The year-over-year drop in revenue and earnings contrasts with prior expectations for steady growth, prompting fresh questions about the resilience of IGI’s underwriting and portfolio management approach. We’ll now examine how this softer quarterly...

In its most recent quarter, TJX Companies reported earnings and revenue ahead of expectations, continuing its pattern of outperformance as an off‑price retailer of branded apparel and home goods. At the same time, management signaled more moderate growth ahead even as analysts remained broadly optimistic, underscoring a tension between strong current execution and tempered future guidance. With robust recent results but more measured growth guidance, we’ll now explore how this shapes TJX’s...